HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 29.45
-0.81 (-2.68%)
At close: Feb 13, 2026
HitGen Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 498.28 | 426.76 | 371.07 | 329.65 | 311.06 | 243.6 |
Other Revenue | 0.23 | 0.23 | 0.26 | - | - | - |
| 498.51 | 426.99 | 371.32 | 329.65 | 311.06 | 243.6 | |
Revenue Growth (YoY) | 17.61% | 14.99% | 12.64% | 5.98% | 27.69% | -7.80% |
Cost of Revenue | 221.4 | 205.55 | 188.45 | 172.49 | 164.78 | 50.27 |
Gross Profit | 277.11 | 221.44 | 182.87 | 157.16 | 146.27 | 193.33 |
Selling, General & Admin | 90.36 | 90.02 | 90.86 | 89.79 | 77.18 | 52.28 |
Research & Development | 58.55 | 66.8 | 79.38 | 87.17 | 73.51 | 98.41 |
Other Operating Expenses | -32.73 | -17.13 | -0.36 | -0.86 | -1.31 | 1.32 |
Operating Expenses | 117.69 | 141.21 | 172.65 | 178.37 | 149.39 | 151.65 |
Operating Income | 159.43 | 80.23 | 10.22 | -21.21 | -3.11 | 41.68 |
Interest Expense | -12.08 | -13.04 | -13.04 | -9.83 | -6.56 | -0.84 |
Interest & Investment Income | 21.7 | 29.11 | 26.92 | 20.13 | 23.53 | 18.92 |
Currency Exchange Gain (Loss) | -0.11 | -0.11 | -0.07 | 19.61 | -5.15 | -21.17 |
Other Non Operating Income (Expenses) | 5.33 | -0.15 | -0.19 | -0.09 | -0.15 | -0.08 |
EBT Excluding Unusual Items | 174.27 | 96.05 | 23.84 | 8.6 | 8.56 | 38.51 |
Impairment of Goodwill | - | - | -13.03 | -11.76 | - | - |
Gain (Loss) on Sale of Investments | -38.63 | -38.68 | -1.28 | 1.35 | -1.15 | - |
Gain (Loss) on Sale of Assets | 0.79 | 0.79 | 0.95 | - | -0.01 | -0.06 |
Asset Writedown | - | - | - | - | - | -0.51 |
Other Unusual Items | 5.03 | 4.6 | 24.97 | 14.25 | 48.44 | 25.41 |
Pretax Income | 141.46 | 62.76 | 35.44 | 12.44 | 55.83 | 63.36 |
Income Tax Expense | 28.45 | 12.84 | -5.42 | -13.05 | -7.55 | -0.67 |
Earnings From Continuing Operations | 113.02 | 49.92 | 40.86 | 25.5 | 63.38 | 64.02 |
Minority Interest in Earnings | 1.09 | 1.43 | -0.14 | -0.23 | - | - |
Net Income | 114.11 | 51.36 | 40.72 | 25.27 | 63.38 | 64.02 |
Net Income to Common | 114.11 | 51.36 | 40.72 | 25.27 | 63.38 | 64.02 |
Net Income Growth | 117.13% | 26.13% | 61.16% | -60.14% | -1.00% | -46.77% |
Shares Outstanding (Basic) | 416 | 395 | 407 | 421 | 396 | 377 |
Shares Outstanding (Diluted) | 416 | 395 | 407 | 421 | 396 | 377 |
Shares Change (YoY) | 0.06% | -2.98% | -3.31% | 6.30% | 5.19% | 3.34% |
EPS (Basic) | 0.27 | 0.13 | 0.10 | 0.06 | 0.16 | 0.17 |
EPS (Diluted) | 0.27 | 0.13 | 0.10 | 0.06 | 0.16 | 0.17 |
EPS Growth | 117.00% | 30.00% | 66.67% | -62.50% | -5.88% | -48.48% |
Free Cash Flow | 79.68 | 56.34 | 71.47 | -34.61 | -96.37 | -81.13 |
Free Cash Flow Per Share | 0.19 | 0.14 | 0.18 | -0.08 | -0.24 | -0.21 |
Dividend Per Share | 0.060 | 0.060 | 0.050 | - | 0.050 | 0.050 |
Dividend Growth | 20.00% | 20.00% | - | - | - | -60.00% |
Gross Margin | 55.59% | 51.86% | 49.25% | 47.67% | 47.02% | 79.36% |
Operating Margin | 31.98% | 18.79% | 2.75% | -6.44% | -1.00% | 17.11% |
Profit Margin | 22.89% | 12.03% | 10.97% | 7.66% | 20.38% | 26.28% |
Free Cash Flow Margin | 15.98% | 13.20% | 19.25% | -10.50% | -30.98% | -33.30% |
EBITDA | 196.29 | 117.28 | 47.52 | 16.82 | 36.71 | 60.64 |
EBITDA Margin | 39.38% | 27.47% | 12.80% | 5.10% | 11.80% | 24.89% |
D&A For EBITDA | 36.86 | 37.05 | 37.3 | 38.03 | 39.82 | 18.95 |
EBIT | 159.43 | 80.23 | 10.22 | -21.21 | -3.11 | 41.68 |
EBIT Margin | 31.98% | 18.79% | 2.75% | -6.44% | -1.00% | 17.11% |
Effective Tax Rate | 20.11% | 20.45% | - | - | - | - |
Revenue as Reported | 498.51 | 426.99 | 371.32 | 329.65 | 311.06 | 243.6 |
Advertising Expenses | - | 0.54 | 0.43 | 0.6 | 0.3 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.